In support of the critical role of TGF-β in the BBB in AD, multiple independent single-cell/nuclear RNA sequencing studies [44–47] have recently identified TGF-β signaling as a major regulator of AD pathology in vascular cells. Here, TGFB1 is linked to Alzheimer disease.